Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 2, 2024
Reply
Carla G S Saad, Ana Cristina Medeiros-Ribeiro, Clarissa Q Pimentel, et al.
Clinical and Experimental Rheumatology
|
February 22, 2018
Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity?
Leandro L Prado, Celio R Goncalves, Vilma T Viana, et al.
Clinical Rheumatology
|
February 6, 2013
NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study
Julio C B Moraes, Ana C M Ribeiro, Carla G S Saad, et al.
Clinical and Experimental Rheumatology
|
December 3, 2011
Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger?
Solange Carrasco, Fabricio S Neves, Marcela H Fonseca, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 24, 2015
Periodontitis Response to Anti-TNF Therapy in Ankylosing Spondylitis
Gisele Maria C Fabri, Rosa Maria R Pereira, Cynthia Savioli, et al.
Bone
|
February 2, 2019
Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT)
Valeria F Caparbo, Pedro Furlam, Carla G S Saad, et al.
Arthritis Research & Therapy
|
February 26, 2016
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients
Fernanda Manente Milanez, Carla G S Saad, Vilma T Viana, et al.
Advances in Rheumatology (London, England)
|
January 19, 2019
Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors
Andrea Y Shimabuco, Celio R Gonçalves, Julio C B Moraes, et al.
Clinics (Sao Paulo, Brazil)
|
March 26, 2013
Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy
Renata Miossi, Ricardo Fuller, Júlio C B Moraes, et al.
Arthritis Research & Therapy
|
October 16, 2012
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Carla G S Saad, Ana C M Ribeiro, Julio C B Moraes, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 2, 2024
Reply
Carla G S Saad, Ana Cristina Medeiros-Ribeiro, Clarissa Q Pimentel, et al.
Clinical and Experimental Rheumatology
|
February 22, 2018
Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity?
Leandro L Prado, Celio R Goncalves, Vilma T Viana, et al.
Clinical Rheumatology
|
February 6, 2013
NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study
Julio C B Moraes, Ana C M Ribeiro, Carla G S Saad, et al.
Clinical and Experimental Rheumatology
|
December 3, 2011
Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger?
Solange Carrasco, Fabricio S Neves, Marcela H Fonseca, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 24, 2015
Periodontitis Response to Anti-TNF Therapy in Ankylosing Spondylitis
Gisele Maria C Fabri, Rosa Maria R Pereira, Cynthia Savioli, et al.
Bone
|
February 2, 2019
Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT)
Valeria F Caparbo, Pedro Furlam, Carla G S Saad, et al.
Arthritis Research & Therapy
|
February 26, 2016
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients
Fernanda Manente Milanez, Carla G S Saad, Vilma T Viana, et al.
Advances in Rheumatology (London, England)
|
January 19, 2019
Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors
Andrea Y Shimabuco, Celio R Gonçalves, Julio C B Moraes, et al.
Clinics (Sao Paulo, Brazil)
|
March 26, 2013
Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy
Renata Miossi, Ricardo Fuller, Júlio C B Moraes, et al.
Arthritis Research & Therapy
|
October 16, 2012
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Carla G S Saad, Ana C M Ribeiro, Julio C B Moraes, et al.
Page
of 4